GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia
BLOOD (2019)
Journal
BLOOD
Volume 132, Issue 12, Pages 935-945Publisher
AMER SOC HEMATOLOGY
Keywords
Categories
Ask authors/readers for more resources
Authors
I am an author on this paper
Reviews
Recommended
Invasive Fungal Disease in Patients with Newly Diagnosed Acute Myeloid Leukemia
Anastasia I. Wasylyshyn, Kathleen A. Linder, Carol A. Kauffman, Blair J. Richards, Stephen M. Maurer, Virginia M. Sheffield, Lydia Benitez Colon, Marisa H. Miceli
JOURNAL OF FUNGI (2021)
Updates in the Management of Newly Diagnosed Acute Myeloid Leukemia
Alice S. Mims
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
How I treat newly diagnosed and refractory T-cell acute lymphoblastic lymphoma in children and young adults
Stephanie J. Si Lim, James B. Ford, Michelle L. Hermiston
BLOOD (2023)
Epidemiology of invasive fungal diseases in adults with newly diagnosed acute myeloid leukemia
Eugenia Miranti, Dora Y. Ho, Kyle Enriquez, Aruna K. Subramanian, Bruno C. Medeiros, David J. Epstein
LEUKEMIA & LYMPHOMA (2022)
Optimizing Treatment Options for Newly Diagnosed Acute Myeloid Leukemia in Older Patients with Comorbidities
Gaku Oshikawa, Koji Sasaki
CANCERS (2023)
SAMHD1 single nucleotide polymorphisms impact outcome in children with newly diagnosed acute myeloid leukemia
Richard J. Marrero, Xueyuan Cao, Huiyun Wu, Abdelrahman H. Elsayed, Jeffery M. Klco, Raul C. Ribeiro, Jeffrey E. Rubnitz, Xiaotu Ma, Soheil Meshinchi, Richard Aplenc, E. Anders Kolb, Rhonda E. Ries, Todd A. Alonzo, Stanley B. Pounds, Jatinder K. Lamba
BLOOD ADVANCES (2023)
Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients
Sylvain Garciaz, Marie-Anne Hospital, Anne-Sophie Alary, Colombe Saillard, Yosr Hicheri, Bilal Mohty, Jerome Rey, Evelyne D'Incan, Aude Charbonnier, Ferdinand Villetard, Valerio Maisano, Laura Lombardi, Antoine Ittel, Marie-Joelle Mozziconacci, Veronique Gelsi-Boyer, Norbert Vey
CANCERS (2022)
Patient-reported symptom monitoring and adherence to therapy in patients with newly diagnosed chronic myeloid leukemia
Fabio Efficace, Francesco Cottone, Betina Yanez, Vamsi Kota, Fausto Castagnetti, Giovanni Caocci, Massimiliano Bonifacio, Andrea Patriarca, Isabella Capodanno, Maria Cristina Miggiano, Mario Tiribelli, Massimo Breccia, Luigia Luciano, Valentina Giai, Alessandra Iurlo, Elisabetta Abruzzese, Carmen Fava, Shira Dinner, Jessica K. Altman, Gianantonio Rosti, Jorge Cortes, Marco Vignetti, David Cella
CANCER (2023)
Glasdegib in newly diagnosed acute myeloid leukemia
Shawn M. Sarkaria, Mark L. Heaney
EXPERT REVIEW OF ANTICANCER THERAPY (2021)
MRD-directed and risk-adapted individualized stratified treatment of AML
Yijing Zhao, Hanfei Guo, Yingjun Chang
CHINESE JOURNAL OF CANCER RESEARCH (2023)
Risk adapted therapeutic strategy in newly diagnosed acute myeloid leukemia: Refining the outcomes of ELN 2017 intermediate-risk patients
Razan Mohty, Radwan Massoud, Zaher Chakhachiro, Rami Mahfouz, Samer Nassif, Jean El-Cheikh, Ali Bazarbachi, Iman Abou Dalle
LEUKEMIA RESEARCH (2021)
Outcomes in patients with newly diagnosed TP53-mutated acute myeloid leukemia with or without venetoclax-based therapy
Sangeetha Venugopal, Mahran Shoukier, Marina Konopleva, Courtney D. Dinardo, Farhad Ravandi, Nicholas J. Short, Michael Andreeff, Gautam Borthakur, Naval Daver, Naveen Pemmaraju, Koji Sasaki, Guillermo Montalban-Bravo, Kayleigh R. Marx, Sherry Pierce, Uday R. Popat, Elizabeth J. Shpall, Rashmi Kanagal-Shamanna, Guillermo Garcia-Manero, Hagop M. Kantarjian, Tapan M. Kadia
CANCER (2021)
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
Michael Heuser, Sylvie D. Freeman, Gert J. Ossenkoppele, Francesco Buccisano, Christopher S. Hourigan, Lok Lam Ngai, Jesse M. Tettero, Costa Bachas, Constance Baer, Marie-Christine Bene, Veit Bucklein, Anna Czyz, Barbara Denys, Richard Dillon, Michaela Feuring-Buske, Monica L. Guzman, Torsten Haferlach, Lina Han, Julia K. Herzig, Jeffrey L. Jorgensen, Wolfgang Kern, Marina Y. Konopleva, Francis Lacombe, Marta Libura, Agata Majchrzak, Luca Maurillo, Yishai Ofran, Jan Philippe, Adriana Plesa, Claude Preudhomme, Farhad Ravandi, Christophe Roumier, Marion Subklewe, Felicitas Thol, Arjan A. van de Loosdrecht, Bert A. van der Reijden, Adriano Venditti, Agnieszka Wierzbowska, Peter J. M. Valk, Brent L. Wood, Roland B. Walter, Christian Thiede, Konstanze Dohner, Gail J. Roboz, Jacqueline Cloos
BLOOD (2021)
Population modeling of bosutinib exposure-response in patients with newly diagnosed chronic phase chronic myeloid leukemia
May Garrett, Beverly Knight, Jorge E. Cortes, Michael W. Deininger
CANCER MEDICINE (2023)
Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the PETHEMA Registry
Jorge Labrador, David Martinez-Cuadron, Adolfo de la Fuente, Rebeca Rodriguez-Veiga, Josefina Serrano, Mar Tormo, Eduardo Rodriguez-Arboli, Fernando Ramos, Teresa Bernal, Maria Lopez-Pavia, Fernanda Trigo, Maria Pilar Martinez-Sanchez, Juan-Ignacio Rodriguez-Gutierrez, Carlos Rodriguez-Medina, Cristina Gil, Daniel Garcia Belmonte, Susana Vives, Maria-Angeles Foncillas, Manuel Perez-Encinas, Andres Novo, Isabel Recio, Gabriela Rodriguez-Macias, Juan Miguel Bergua, Victor Noriega, Esperanza Lavilla, Alicia Roldan-Perez, Miguel A. Sanz, Pau Montesinos
CANCERS (2022)
ENABLE: treatment combination including decitabine and venetoclax in acute myeloid leukemia secondary to myeloproliferative neoplasms
Francesco Mannelli, Paola Guglielmelli, Paola Fazi, Enrico Crea, Alfonso Piciocchi, Marco Vignetti, Sergio Amadori, Fabrizio Pane, Adriano Venditti, Alessandro M. Vannucchi
FUTURE ONCOLOGY (2023)
The Cytotoxic Effect of Curcumin in Rhabdomyosarcoma Is Associated with the Modulation of AMPK, AKT/mTOR, STAT, and p53 Signaling
Sara Salucci, Alberto Bavelloni, Anna Bartoletti Stella, Francesco Fabbri, Ivan Vannini, Manuela Piazzi, Karyna Volkava, Katia Scotlandi, Giovanni Martinelli, Irene Faenza, William Blalock
NUTRIENTS (2023)
Time for Dynamic Assessment of Fitness in Acute Myeloid Leukemia
Raffaele Palmieri, Luca Maurillo, Maria Ilaria Del Principe, Giovangiacinto Paterno, Roland Bruno Walter, Adriano Venditti, Francesco Buccisano
CANCERS (2023)
Measurable Residual Disease and Clonal Evolution in Acute Myeloid Leukemia from Diagnosis to Post-Transplant Follow-Up: The Role of Next-Generation Sequencing
Alessandra Sperotto, Maria Teresa Bochicchio, Giorgia Simonetti, Francesco Buccisano, Jacopo Peccatori, Simona Piemontese, Elisabetta Calistri, Giulia Ciotti, Elisabetta Pierdomenico, Roberta De Marchi, Fabio Ciceri, Michele Gottardi
BIOMEDICINES (2023)
Comparison between azacitidine and decitabine as front-line therapy in elderly acute myeloid leukemia patients not eligible for intensive chemotherapy
L. Maurillo, A. Spagnoli, A. Candoni, C. Papayannidis, E. Borlenghi, D. Lazzarotto, L. Fianchi, M. Sciume, M. E. Zannier, F. Buccisano, M. I. Del Principe, V. Mancini, M. Breccia, R. Fanin, E. Todisco, M. Lunghi, R. Palmieri, N. Fracchiolla, P. Musto, G. Rossi, A. Venditti
LEUKEMIA RESEARCH (2023)
Acute leukemia diagnosis during the COVID-19 pandemic
Luca Guarnera, Elisa Buzzatti, Francesco Marchesi, Daniele Armiento, Carla Mazzone, Saveria Capria, Emilia Scalzulli, Francesco Malfona, Sabina Chiaretti, Raffaele Palmieri, Giovangiacinto Paterno, Chiara Franzese, Fabrizio Bonanni, Arianna Savi, Gianmario Pasqualone, Federico Moretti, Luca Maurillo, Francesco Buccisano, Adriano Venditti, Maria Ilaria Del Principe
PANMINERVA MEDICA (2023)
Acute myeloid leukemia: Incidence, transplantation and survival through Italian administrative healthcare data
Silvia Calabria, Giulia Ronconi, Letizia Dondi, Carlo Piccinni, Antonella Pedrini, Immacolata Esposito, Alice Addesi, Giuseppe Rossi, Felicetto Ferrara, Adriano Venditti, Nello Martini
TUMORI JOURNAL (2023)
The baseline comorbidity burden affects survival in elderly patients with acute myeloid leukemia receiving hypomethylating agents: Results from a multicentric clinical study
Giovanni Marconi, Anna Candoni, Roberta Di Nicola, Chiara Sartor, Sarah Parisi, Mariachiara Abbenante, Jacopo Nanni, Gianluca Cristiano, Letizia Zannoni, Davide Lazzarotto, Benedetta Giannini, Carmen Baldazzi, Lorenza Bandini, Emanuela Ottaviani, Nicoletta Testoni, Chiara Di Giovanni Bezzi, Rania Abd-alatif, Giulia Ciotti, Renato Fanin, Giovanni Martinelli, Stefania Paolini, Paolo Ricci, Michele Cavo, Cristina Papayannidis, Antonio Curti
CANCER MEDICINE (2023)
Detection of a Novel MSI2-C17orf64 Transcript in a Patient with Aggressive Adenocarcinoma of the Gastroesophageal Junction: A Case Report
Anna Ferrari, Roberto Fiocca, Elena Bonora, Chiara Domizio, Eugenio Fonzi, Davide Angeli, Gian Domenico Raulli, Sandro Mattioli, Giovanni Martinelli, Chiara Molinari
GENES (2023)
Correlations between Molecular Alterations, Histopathological Characteristics, and Poor Prognosis in Esophageal Adenocarcinoma
Arianna Orsini, Luca Mastracci, Isotta Bozzarelli, Anna Ferrari, Federica Isidori, Roberto Fiocca, Marialuisa Lugaresi, Antonietta D'Errico, Deborah Malvi, Erica Cataldi-Stagetti, Paola Spaggiari, Anna Tomezzoli, Luca Albarello, Ari Ristimaki, Luca Bottiglieri, Kausilia K. Krishnadath, Riccardo Rosati, Uberto Fumagalli Romario, Giovanni De Manzoni, Jari Rasanen, Giovanni Martinelli, Sandro Mattioli, Elena Bonora
CANCERS (2023)
Consensus for Flow Cytometry Clinical Report on Multiple Myeloma: A Multicenter Harmonization Process Merging Laboratory Experience and Clinical Needs
Iole Cordone, Rachele Amodeo, Silvia Bellesi, Fiorella Bottan, Francesco Buccisano, Maria Stefania De Propris, Serena Masi, Valentina Panichi, Maria Cristina Scerpa, Ombretta Annibali, Velia Bongarzoni, Tommaso Caravita di Toritto, Ugo Coppetelli, Luca Cupelli, Paolo de Fabritiis, Luca Franceschini, Mariagrazia Garzia, Alessia Fiorini, Giacinto Laverde, Andrea Mengarelli, Tommaso Za, Maria Teresa Petrucci
CANCERS (2023)
The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer
Giuseppe Schepisi, Caterina Gianni, Michela Palleschi, Sara Bleve, Chiara Casadei, Cristian Lolli, Laura Ridolfi, Giovanni Martinelli, Ugo De Giorgi
CANCERS (2023)
Azacitidine Post-Remission Therapy for Elderly Patients with AML: A Randomized Phase-3 Trial (QoLESS AZA-AMLE)
Esther Natalie Oliva, Anna Candoni, Prassede Salutari, Giuseppe A. Palumbo, Gianluigi Reda, Giuseppe Ianni, Giovanni Tripepi, Maria Cuzzola, Debora Capelli, Corrado Mammi, Caterina Alati, Maria Concetta Cannata, Pasquale Niscola, Bianca Serio, Pellegrino Musto, Ernesto Vigna, Antonio Volpe, Lorella Maria Antonia Melillo, Maria Teresa Arcadi, Donato Mannina, Maria Elena Zannier, Roberto Latagliata
CANCERS (2023)
Preclinical Validation of an Advanced Therapy Medicinal Product Based on Cytotoxic T Lymphocytes Specific for Mutated Nucleophosmin (NPM1mut) for the Treatment of NPM1mut-Acute Myeloid Leukemia
Marica De Cicco, Ivana Lagreca, Sabrina Basso, Patrizia Barozzi, Stella Muscianisi, Alba Bianco, Giovanni Riva, Sara Di Vincenzo, Chiara Pulvirenti, Davide Sapuppo, Mariangela Siciliano, Vittorio Rosti, Anna Candoni, Marco Zecca, Fabio Forghieri, Mario Luppi, Patrizia Comoli
CANCERS (2023)
Real-world evaluation of UK high hyperdiploidy profile using a large cohort of patients provided by HARMONY data platform
Amir Enshaei, Javier Martinez Elicegui, Esther Anguiano, Jude Gibson, Sulaiman Lawal, Mirella Ampatzidou, Michael Doubek, Adele K. Fielding, Edoardo La Sala, Elizabeth Middleton, Anita W. Rijneveld, Amin T. Turki, Martin Zimmermann, Ajay Vora, Anthony V. Moorman
LEUKEMIA (2023)